NIR Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After iv Injection of ICG
NCT02027831 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2014-07-24
Summary
The purpose of this study is to determine if NIR fluorescent imaging is an effective approach to detect the margins of head and neck tumours or lymph nodes draining the tumour
Conditions
Interventions
- DRUG
-
Indocyanine Green
Sponsors & Collaborators
-
Jules Bordet Institute
lead OTHER
Principal Investigators
-
Antoine Digonnet, MD · Jules Bordet Institute
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2014-10-31
- Completion
- 2014-10-31
Countries
- Belgium
Study Locations
More Related Trials
-
Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer
NCT00135161 ·Status: COMPLETED ·Phase: PHASE1
-
[18F]-AraG PET Imaging in LA HNSCC
NCT07168785 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
NCT06914999 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients
NCT01834469 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Fluorescence Imaging in Head and Neck Cancer
NCT03297957 ·Status: TERMINATED ·Phase: NA
-
Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma
NCT01827709 ·Status: TERMINATED ·Phase: NA
-
Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)
NCT00147472 ·Status: COMPLETED ·Phase: PHASE3
-
Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
NCT02678884 ·Status: RECRUITING ·Phase: NA
-
123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors
NCT01373736 ·Status: UNKNOWN ·Phase: PHASE3
-
Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT
NCT05068687 ·Status: COMPLETED ·Phase: NA
-
Prognostic Value of Pre-therapy 18F-FDG PET/CT for the Outcome of 18 FDG PET-guided SIB-IMRT in Patients With Head and Neck Cancer
NCT06171464 ·Status: COMPLETED
-
Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma
NCT00634777 ·Status: UNKNOWN ·Phase: NA
-
Development of Photoacoustic Tomography
NCT03501823 ·Status: UNKNOWN
-
Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer
NCT02469922 ·Status: COMPLETED ·Phase: NA
-
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
NCT01806675 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
MRI and PET-CT for Radiotherapy Planning for Head and Neck Cancer
NCT02273778 ·Status: COMPLETED ·Phase: NA
-
PET/CT: Role in Detecting Unknown Primary Head and Neck Cancer
NCT00656760 ·Status: COMPLETED ·Phase: NA
-
Mapping of Sentinel Lymph Node Drainage Using SPECT (SUSPECT) (SUSPECT)
NCT02572661 ·Status: COMPLETED ·Phase: NA
-
[18F]HX4 PET/CT Imaging for Detection of Hypoxia
NCT02976883 ·Status: COMPLETED ·Phase: PHASE2
-
PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy
NCT00809016 ·Status: COMPLETED ·Phase: NA
-
SPIO-enhanced MRI in Oral Cancer for Sentinel Lymph Node Identification
NCT04803331 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy
NCT01663753 ·Status: COMPLETED ·Phase: NA
-
Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
NCT00313027 ·Status: COMPLETED ·Phase: NA
-
PET CT With HX4 in Cervix Cancer
NCT02233387 ·Status: TERMINATED ·Phase: PHASE2
-
Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.
NCT00782691 ·Status: UNKNOWN